Luo et al. discovered that miR-3613-5p is upregulated in extracellular vesicles of breast cancer and regulates progression by targeting the tumor suppressor gene PTEN, enhancing resistance to doxorubicin (Luo et al., 2022). The gene discussed is PTEN; the disease is breast carcinoma.